Form 4: HealthLynked CFO David Rosal Reports Acquisition of Common Stock
SEC Form 4 Filing
David Rosal, CFO of HealthLynked Corp, reports acquiring common stock through open market purchases.
Summary
- David Rosal, the Chief Financial Officer of HealthLynked Corp, filed a Form 4 detailing changes in beneficial ownership.
- On June 20, 2024, Rosal acquired 33,667 shares of common stock at a price of $0.08 per share.
- On June 24, 2024, Rosal acquired an additional 28,333 shares of common stock at a price of $0.084 per share.
- Following these transactions, Rosal directly owns 62,000 shares of HealthLynked Corp common stock.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. The CFO's stock purchase is a positive sign, but it's a relatively small transaction.
Positives
- The CFO's purchase of shares could be interpreted as a sign of confidence in the company's future prospects.
Industry Context
Insider buying is often seen as a positive signal, suggesting that a company insider believes the company's stock is undervalued.
Stakeholder Impact
- Shareholders may view the CFO's stock purchase as a positive signal.
Key Dates
| Date | Description |
|---|---|
| 06/20/2024 | Rosal acquired 33,667 shares of common stock at $0.08 per share. |
| 06/24/2024 | Rosal acquired 28,333 shares of common stock at $0.084 per share. |
| 06/24/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.